Encompass Health Corporation $EHC Shares Acquired by Cinctive Capital Management LP

Cinctive Capital Management LP increased its position in Encompass Health Corporation (NYSE:EHC) by 48.6% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 66,898 shares of the company’s stock after purchasing an additional 21,887 shares during the period. Cinctive Capital Management LP owned 0.07% of Encompass Health worth $8,497,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Citizens National Bank Trust Department bought a new stake in shares of Encompass Health in the 3rd quarter valued at approximately $26,000. First Horizon Corp acquired a new position in Encompass Health in the third quarter worth $34,000. Westside Investment Management Inc. increased its stake in Encompass Health by 56.7% during the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock valued at $35,000 after purchasing an additional 101 shares during the last quarter. Assetmark Inc. increased its stake in Encompass Health by 88.1% during the third quarter. Assetmark Inc. now owns 299 shares of the company’s stock valued at $38,000 after purchasing an additional 140 shares during the last quarter. Finally, Root Financial Partners LLC acquired a new stake in shares of Encompass Health during the third quarter worth $39,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Insider Activity at Encompass Health

In other Encompass Health news, CEO Mark J. Tarr sold 150,000 shares of Encompass Health stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the sale, the chief executive officer owned 377,070 shares of the company’s stock, valued at $42,096,094.80. The trade was a 28.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Treasurer Edmund Fay sold 11,937 shares of the business’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $107.00, for a total value of $1,277,259.00. Following the transaction, the treasurer owned 89,325 shares of the company’s stock, valued at $9,557,775. This trade represents a 11.79% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 2.00% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC opened at $100.52 on Friday. The firm has a fifty day moving average of $103.58 and a 200-day moving average of $112.98. The company has a market cap of $9.99 billion, a price-to-earnings ratio of 18.14, a price-to-earnings-growth ratio of 1.92 and a beta of 0.71. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 1.08. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. The business had revenue of $3.09 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The company’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, equities analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Wednesday, April 1st. Encompass Health’s payout ratio is 13.72%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on EHC. Barclays lifted their price target on shares of Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a report on Friday, February 6th. Zacks Research downgraded Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Finally, Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $143.29.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.